Our Bond, Inc. Amends Warrants with Deep Price Cuts, Secures $2.5M High-Interest Promissory Note

summarizeSummary

Our Bond, Inc. amended 12 million warrants with significantly reduced exercise prices and secured a $2.5 million high-interest promissory note, indicating an urgent need for capital despite potential dilution and high debt costs.

check_boxKey Events

• Warrant Exercise Price Reduction

  Our Bond, Inc. amended outstanding warrants for 12,000,000 shares, significantly lowering exercise prices from $12.35 to a range of $2.25 to $3.25 for a 90-day period. This move aims to incentivize warrant holders to exercise, potentially raising approximately $32.6 million for the company, though the warrants remain out-of-the-money at the current stock price.

• New Promissory Note Issued

  The company entered into a $2.5 million promissory note with Ascent Partners Fund, LLC, bearing a 10% annual interest rate and maturing on September 1, 2026. The note includes a mandatory prepayment clause requiring 25% of future offering proceeds and a default interest rate of 24%.

auto_awesomeAnalysis

Our Bond, Inc. has undertaken a critical financing maneuver by significantly reducing the exercise prices for 12 million outstanding warrants. While the new exercise prices ($2.25, $2.75, $3.25) are still above the current stock price of $1.89, making the warrants currently out-of-the-money, the substantial reduction from the original $12.35 exercise price indicates a strong incentive to encourage future exercise and secure capital. If all 12 million warrants are exercised at these new prices, the company could potentially raise approximately $32.6 million, a significant amount relative to its current market capitalization, but this would also lead to substantial dilution for existing shareholders. Concurrently, the company secured a $2.5 million promissory note with a high 10% annual interest rate, escalating to 24% upon default, and a maturity date of September 1, 2026. The note includes a mandatory prepayment clause, requiring 25% of net proceeds from future equity offerings to be applied towards its repayment, further linking this debt to potential future dilution. These financing activities highlight the company's urgent need for capital, accepting highly dilutive terms for warrants and high-cost debt to secure funding, signaling financial strain.